Evidence map›Paper›PMID 24419112›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer.

Guy H Montgomery, Daniel David, Maria Kangas, Sheryl Green, Madalina Sucala, Dana H Bovbjerg, Michael N Hallquist, Julie B Schnur

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03429296 (Prospective, Randomized Study Aiming to Assess the Benefit of Autohypnosis Learning in the Care of Patients Treated by Adjuvant Chemotherapy for Colorectal or Breast Cancer.), which is not on this map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03429296 nacompletednot on this mapstarted 2018, after this paper: background citation

Prospective, Randomized Study Aiming to Assess the Benefit of Autohypnosis Learning in the Care of Patients Treated by Adjuvant Chemotherapy for Colorectal or Breast Cancer.

TypeinterventionalSponsorGroupe Hospitalier Mutualiste de GrenobleRan2018 to 2022Enrolled120ConditionsColorectal Cancer, Breast CancerArmsAutohypnosis learning
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Guideline
  2. Pooled it
  3. Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  4. Pooled it
  5. Guideline
  6. Hypnosis for Symptom Control in Cancer Patients at the End-of-Life: A Systematic Review.The International journal of clinical and experimental hypnosis
    Pooled it
  7. Qualitative similarities and distinctions between participants' experiences with a yoga intervention and an attention control.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Guy H MontgomeryGuy H. Montgomery, Daniel David, Sheryl Green, Madalina Sucala, and Julie B. Schnur, Icahn School of Medicine at Mount Sinai, New York, NY; Daniel David and Madalina Sucala, Babeş-Bolyai University, Cluj-Napoca, Romania; Maria Kangas, Macquarie University, Sydney, New South Wales, Australia; Dana H. Bovbjerg, University of Pittsburgh Cancer Institute, University of Pittsburgh; and Michael N. Hallquist, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA.
Daniel David
Maria Kangas
Sheryl Green
Madalina Sucala
Dana H Bovbjerg
Michael N Hallquist
Julie B Schnur
Babeș-Bolyai University · RO

Funding

CANCER PREVENTION &CONTROL--MULTIDISCIPLINARY TRAININGR25CA081137 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MONTGOMERY, GUY H · 1999 to 2014
$6.7M
A Presurgery Hypnosis Training Program for Nurse AnesthetistsR25CA129094 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MONTGOMERY, GUY H · 2007 to 2011
$1.5M
E-Counseling in psychosocial cancer care: A competency-based E-Learning approachR25CA166042 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MONTGOMERY, GUY H · 2012 to 2016
$1.5M
Skin Toxicity Effects in Breast Radiation: A Cognitive Behavioral InterventionK07CA131473 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNUR, JULIE B. · 2008 to 2012
$637k
Developing a Skin Toxicity-Related Quality of Life Scale for Breast RadiotherapyR03CA159530 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNUR, JULIE B. · 2011 to 2012
$168k
NCI NIH HHS CA081137NCI NIH HHS CA129094NCI NIH HHS CA131473NCI NIH HHS CA159530NCI NIH HHS CA166042NCI NIH HHS K07 CA131473NCI NIH HHS R03 CA159530NCI NIH HHS R25 CA081137NCI NIH HHS R25 CA129094NCI NIH HHS R25 CA166042
6 · The paper itself

Abstract

purposeThe objective of this study was to test the efficacy of cognitive-behavioral therapy plus hypnosis (CBTH) to control fatigue in patients with breast cancer undergoing radiotherapy. We hypothesized that patients in the CBTH group receiving radiotherapy would have lower levels of fatigue than patients in an attention control group. PATIENTS AND

methodsPatients (n = 200) were randomly assigned to either the CBTH (n = 100; mean age, 55.59 years) or attention control (n = 100; mean age, 55.97 years) group. Fatigue was measured at four time points (baseline, end of radiotherapy, 4 weeks, and 6 months after radiotherapy). Fatigue was measured using the Functional Assessment of Chronic Illness Therapy (FACIT) -Fatigue subscale and Visual Analog Scales (VASs; Fatigue and Muscle Weakness).

resultsThe CBTH group had significantly lower levels of fatigue (FACIT) at the end of radiotherapy (z, 6.73; P < .001), 4-week follow-up (z, 6.98; P < .001), and 6-month follow-up (z, 7.99; P < .001) assessments. Fatigue VAS scores were significantly lower in the CBTH group at the end of treatment (z, 5.81; P < .001) and at the 6-month follow-up (z, 4.56; P < .001), but not at the 4-week follow-up (P < .07). Muscle Weakness VAS scores were significantly lower in the CBTH group at the end of treatment (z, 9.30; P < .001) and at the 6-month follow-up (z, 3.10; P < .02), but not at the 4-week follow-up (P < .13).

conclusionThe results support CBTH as an evidence-based intervention to control fatigue in patients undergoing radiotherapy for breast cancer. CBTH is noninvasive, has no adverse effects, and its beneficial effects persist long after the last intervention session. CBTH seems to be a candidate for future dissemination and implementation.

Indexed as

Breast NeoplasmsCognitive Behavioral TherapyFatigueFemaleHumansHypnosisMiddle AgedQuality of LifeTreatment Outcome

Identifiers

PMID24419112
PMCPMC3918539
OpenAlexW2096202341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.